Status:
COMPLETED
European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes
Lead Sponsor:
AstraZeneca
Conditions:
Acute Bipolar Manic Episode
Eligibility:
All Genders
18+ years
Brief Summary
This study is being carried out to find out how patients suffering from the acute manic phase of bipolar disease are currently managed with Quetiapine Immediate Release (IR) or Quetiapine Extended Rel...
Eligibility Criteria
Inclusion
- Patients diagnosed with Bipolar Disorder (ICD-10).
- Admitted for acute bipolar manic episode from 1st October 2009 to 1st October 2010
- Patients treated with quetiapine IR or quetiapine XR during the hospitalization period.
Exclusion
- Patients in which BD is not the main reason for hospitalization
- Patients admitted for acute bipolar mania episodes but finally diagnosed with mixed or bipolar disorder not otherwise specified (NOS) episodes
- Patients receiving both quetiapine IR and XR during the same hospitalization period.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
1280 Patients enrolled
Trial Details
Trial ID
NCT01239589
Start Date
November 1 2010
End Date
March 1 2011
Last Update
March 29 2011
Active Locations (86)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Assebroek, Belgium, Belgium
2
Research Site
Bertrix, Belgium, Belgium
3
Research Site
Bruges, Belgium, Belgium
4
Research Site
Ghent, Belgium, Belgium